Literature DB >> 9049412

Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after virus entry and is independent of virus tropism.

B Willett1, M Hosie, A Shaw, J Neil.   

Abstract

A monoclonal antibody which blocks infection with feline immunodeficiency virus (FIV) was found previously to react with the cell surface molecule CD9, implicating CD9 in the process of virus entry. We report here that inhibition by anti-CD9 antibody does not operate at the level of virus entry but at a subsequent stage in the virus life-cycle. Moreover, inhibition of infection is independent of the passage history of the virus or the virus subtype. Inhibition of FIV infection by anti-CD9 antibody does not operate in 3201 cells, which do not express this surface antigen. However, ectopic expression of CD9 on 3201 cells enhances infection with FIV, suggesting that the role of CD9 may be direct rather than via cellular signalling pathways. These results suggest a novel control point in the lentivirus life-cycle which might be susceptible to modulation by natural antagonists.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049412     DOI: 10.1099/0022-1317-78-3-611

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding.

Authors:  A de Parseval; D L Lerner; P Borrow; B J Willett; J H Elder
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Tetraspanins in viral infections: a fundamental role in viral biology?

Authors:  F Martin; D M Roth; D A Jans; C W Pouton; L J Partridge; P N Monk; G W Moseley
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion.

Authors:  E Schmid; A Zurbriggen; U Gassen; B Rima; V ter Meulen; J Schneider-Schaulies
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.

Authors:  J Richardson; G Pancino; R Merat; T Leste-Lasserre; A Moraillon; J Schneider-Mergener; M Alizon; P Sonigo; N Heveker
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.

Authors:  H F Egberink; E De Clercq; A L Van Vliet; J Balzarini; G J Bridger; G Henson; M C Horzinek; D Schols
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Authors:  Christelle Brégnard; Alessia Zamborlini; Marjorie Leduc; Philippe Chafey; Luc Camoin; Ali Saïb; Serge Benichou; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

7.  In vivo CXCR4 expression, lymphoid cell phenotype, and feline immunodeficiency virus infection.

Authors:  Sean P Troth; Alan D Dean; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

8.  Tetraspanins: Small transmembrane proteins with big impact on membrane microdomain structures.

Authors:  Katrin Singethan; Jürgen Schneider-Schaulies
Journal:  Commun Integr Biol       Date:  2008

9.  CD9 clustering and formation of microvilli zippers between contacting cells regulates virus-induced cell fusion.

Authors:  Katrin Singethan; Nora Müller; Sabine Schubert; Doreen Lüttge; Dimitry N Krementsov; Sandhya R Khurana; Georg Krohne; Sibylle Schneider-Schaulies; Markus Thali; Jürgen Schneider-Schaulies
Journal:  Traffic       Date:  2008-03-17       Impact factor: 6.215

10.  Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus.

Authors:  Brian J Willett; Celia A Cannon; Margaret J Hosie
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.